SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Keryx Biopharmaceuticals, Inc (KERX)

KERX RSS Feed
Add KERX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/5/2017 6:46:42 PM - Followers: 133 - Board type: Free - Posts Today: 0

 

 

 

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 has demonstrated both safety and clinical efficacy in several tumor types, both as a single agent and in combination with novel therapies. KRX-0401 is currently in Phase 3 clinical development for both multiple myeloma and refractory advanced colorectal cancer, and in Phase 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 programs are being conducted under Special Protocol Assessment (SPA) agreements with the FDA. Keryx is also developing ZerenexTM (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of ZerenexTM in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is pending commencement under an SPA agreement with the FDA. Keryx also actively engages in business development activities that include seeking strategic relationships for its product candidates, as well as evaluating compounds and companies for in-licensing or acquisition.

Keryx is headquartered in New York City.

Keryx Biopharmaceuticals is traded on the Nasdaq Stock Market under the symbol "KERX."





Corporate Headquarters

 

Keryx Biopharmaceuticals, Inc.
750 Lexington Ave. - 20th Floor
New York, NY 10022
Phone: 1-212-531-5965
Fax: 1-212-531-5961
Contact Email
Investor Relations IR@keryx.com
Business Development BusDev@keryx.com
Clinical Trials ClinicalTrials@keryx.com
Employment Opportunities

Company Website
jobs@keryx.com

http://www.keryx.com/



 

Product candidate Target indication Development status
     
ZerenexTM (ferric citrate) Hyperphosphatemia in patients with end-stage renal disease U.S. Phase 3 program ongoing under SPA; 
Japan Phase 3 program ongoing by sublicensee (JT and Torii)

 

Recent News:

http://ih.advfn.com/p.php?pid=news&symbol=N%5EKERX

http://www.otcmarkets.com/stock/KERX/news  

http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-news&nyo=0

Charts:

Gallery views:

http://stockcharts.com/freecharts/gallery.html?kerx


 

                KERX - Daily Candlesticks  


Analyst's estimates and ratings: 
http://investing.money.msn.com/investments/analyst-ratings/?symbol=kerx

http://www.marketwatch.com/investing/stock/KERX/analystestimates?subview=snapshot&pg=analyst

 

The most recent Quarterly (10-Q)
 
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8450533

Do your own DD and trade smart.


 
 
  
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KERX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
KERX News: Quarterly Report (10-q) 05/04/2017 04:38:54 PM
KERX News: Current Report Filing (8-k) 05/04/2017 07:12:47 AM
KERX News: Keryx Biopharmaceuticals Announces First Quarter 2017 Financial Results 05/04/2017 07:02:00 AM
KERX News: Statement of Changes in Beneficial Ownership (4) 05/03/2017 04:08:20 PM
KERX News: Statement of Changes in Beneficial Ownership (4) 05/03/2017 04:07:28 PM
PostSubject
#3003   12$ pps isnt to far away harry crumb 05/05/17 06:46:42 PM
#3002   Cool... thank you for the info! Been a fsulevine 05/05/17 07:59:21 AM
#3001   Keryx Announces that Auryxia® (Ferric Citrate) is Now dave2808 05/05/17 07:05:49 AM
#3000   Keryx Announces that Auryxia® (Ferric Citrate) is Now dave2808 05/05/17 07:03:19 AM
#2999   I have been busy most of the week... fsulevine 05/05/17 06:44:11 AM
#2998   $11.8 million in first quarter 2017 total H2R 05/04/17 10:06:44 AM
#2997   Also hearing their in line to beat earnings dave2808 05/01/17 08:37:59 AM
#2996   Excellent news! Seems as though the company Stockdoggy 05/01/17 08:35:39 AM
#2995   Big news out today for KERX dave2808 05/01/17 08:28:00 AM
#2994   Once approved for CKD in non/pre-dialysis patients, what fsulevine 04/19/17 10:54:21 PM
#2993   It could over the next 12 months dave2808 03/20/17 05:01:48 PM
#2992   time finally for kerx to start making more harry crumb 03/20/17 02:44:56 PM
#2991   Ready to gap up today dave2808 03/20/17 09:10:56 AM
#2990   620 vs 653 chile2 03/10/17 02:52:38 PM
#2989   Thank you for the info! fsulevine 03/05/17 06:52:47 PM
#2988   From Stocktwits Symphony $653k vs $640k Tate 03/03/17 09:39:15 AM
#2987   If anybody has access to the weekly script fsulevine 03/03/17 08:09:27 AM
#2986   "These include continued growth in the U.S. dialysis jammyjames 03/01/17 08:05:17 AM
#2985   Check this out DorseyE 02/22/17 09:05:54 PM
#2984   * * $KERX Video Chart 02-02-17 * * ClayTrader 02/02/17 05:22:52 PM
#2983   Journal of the American Society of Nephrology H2R 01/12/17 10:39:25 AM
#2982   Keryx presentation at JP Morgan conference today: http://seekingalpha.com/artic Radtech 01/11/17 03:07:40 PM
#2981   From the Motley Fool Sunshine52 01/11/17 08:50:02 AM
#2980   Baupost is the largest shareholder, they think Sunshine52 01/10/17 07:44:49 AM
#2979   It's not "IRS" Sunshine52 01/10/17 07:43:28 AM
#2978   Hope u cashed in on ARIA yesterday Sunshine52 01/10/17 07:23:02 AM
#2977   8k looks good heading into 2017! expect this harry crumb 01/10/17 12:19:59 AM
#2976   does anyone know of a successful stock or kennedytrading 12/27/16 05:09:49 PM
#2975   5:52 Just like I thought. redsox17 12/01/16 05:04:24 PM
#2974   I love it Go KERX redsox17 11/17/16 12:23:32 PM
#2973   That's great. Look at the news out today. redsox17 11/17/16 12:19:13 PM
#2972   yeah bought 5k yesterday an flipped it! easy harry crumb 11/17/16 10:20:29 AM
#2971   No worries $ 16.00 dollar stock. redsox17 11/16/16 07:27:20 PM
#2970   Told you back to 5.50 area redsox17 11/16/16 07:25:33 PM
#2969   we dont in this case. 10 is coming harry crumb 11/14/16 06:28:36 AM
#2968   $KERX Day Trading Idea for November 14 https://goo.gl/BEAOQ0 stocktraderMNT 11/14/16 05:23:08 AM
#2966   Harry I see Kerx going back down. redsox17 11/12/16 07:12:49 PM
#2965   Where do you see Kerx going ? redsox17 11/12/16 06:47:41 PM
#2964   buy more kerx, and then more! this will harry crumb 11/12/16 12:28:09 PM
#2963   Harry buy DMTX redsox17 11/11/16 10:51:56 AM
#2962   great news for kerx. up from here harry crumb 11/09/16 03:08:33 PM
#2961   November 9th redsox17 11/01/16 11:08:21 AM
#2960   I wonder why they haven't released their Earnings. smh Tdash 10/28/16 10:17:32 AM
#2959   no worries, watch what is coming! harry crumb 09/24/16 02:03:56 AM
#2958   Hope you're right. I will be happy redsox17 09/15/16 05:14:43 PM
#2957   theres no merrit for any , not 1 harry crumb 09/15/16 01:03:31 PM
#2956   kerx will b 20$ stock, giv it time, harry crumb 09/15/16 12:56:46 PM
#2955   Just playing technical bounce for now. If things rivervalley 09/08/16 11:33:20 AM
#2954   Looking good here. rivervalley 09/08/16 11:15:12 AM
#2953   Any Catalyst? Tdash 09/08/16 11:14:36 AM
PostSubject